.
10 Fold
5 Fold
100 Fold
2 Fold
50 & 50
34 & 66
30 & 70
40 & 60
30-50 HRS
18-24 HRS
24 HRS
32-39 HRS
CYP1A2
CYP3A4
CYP2C19
CYPA4
0.98 nm & 19 nm
0.98 nm & 16.9 nm
7.5 nm &19 nm
None of these
Rs. 23
Rs. 18.75
Rs. 19.75
Rs. 21.85
Evogliptin selectively binds to S1,S2 & S2 extensive sub-units.
Evogliptin selectively binds to S1,S2 sub-units
Evogliptin selectively binds to S1,S2,S1' & S2' extensive sub-units.
Evogliptin selectively binds to S1,S2 & S' sub-units
True
False
Maintain 24hrs concentration and reduces toxicity
Avoid high blood concentration and increased patient compliance
Both A & B
Only A
Glucoryl MV 1/2 0.3
Glucoryl MV 1/2
Glucoryl M 1/2/3/4 Forte
None of these
DPP-4
DPP-8
DPP-9
DPP-8 & DPP-9
Di-hydro Peptidyl Peptidase
Di-Phenyl Peptidase
Di-Peptidepeptidase
Di-Peptidyl Peptidase
Daewoo Pharma
Dong Koo
DONG-A ST
None of these
>3000
>8000
>6000
>10000
True
False
0.8% vs 2.5%
0.9% vs 2.8%
0.2% vs 2%
1% vs 2.6%
True
False
In Dyslipidemia with ASCVD with risk of MI/Stroke/PAD
In Secondary Prevention
Both A & B
None of these
In overweight & obese type 2 Diabetics.
In overweight & obese type 2 Diabetics with elevated FPG & PPG
In T2DM on dual therapy with uncontrolled FPG & HbA1c
In Obese Uncontrolled T2DM Patients